Nabriva Therapeutics plc Proceeds from Long-Term Debt Issued
Nabriva Therapeutics plc reported Proceeds from Long-Term Debt Issued of $9.98 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-03-29
- Nabriva Therapeutics plc proceeds from issuance of long-term debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Nabriva Therapeutics plc proceeds from issuance of long-term debt for the quarter ending 2019-09-30 was $9.90M, a 7820.00% increase year-over-year.
- Nabriva Therapeutics plc proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $23.01M.
- Nabriva Therapeutics plc proceeds from issuance of long-term debt for the quarter ending 2018-09-30 was $125.00K.
- Nabriva Therapeutics plc proceeds from issuance of long-term debt for fiscal 2019 was $9.98M, a 57.61% decline from fiscal 2018.
- Nabriva Therapeutics plc proceeds from issuance of long-term debt for fiscal 2018 was $23.55M, a 10226.75% increase from fiscal 2017.
- Nabriva Therapeutics plc proceeds from issuance of long-term debt for fiscal 2017 was $228.00K.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $9.90M derived: sum of 2 quarters · filed 2022-03-29 | $9.98M 10-K · filed 2022-03-29 | ||
| 2019-09-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.98M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $80.00K 10-Q · filed 2020-08-06 | ||||
| 2018-12-31 | $23.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $23.14M derived: sum of 2 quarters · filed 2021-03-11 | $23.36M derived: sum of 3 quarters · filed 2021-03-11 | $23.55M 10-K · filed 2021-03-11 | $25.54M 10-K · filed 2019-03-12 |
| 2018-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $346.00K derived: sum of 2 quarters · filed 2019-11-12 | $535.00K 10-Q · filed 2019-11-12 | $535.00K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $410.00K 10-Q · filed 2019-08-08 | $410.00K derived: sum of 3 quarters · filed 2020-03-12 | $410.00K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | $189.00K 10-Q · filed 2019-05-10 | $189.00K derived: sum of 2 quarters · filed 2020-03-12 | $189.00K derived: sum of 3 quarters · filed 2020-03-12 | $188.00K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | -$1.00K derived: sum of 3 quarters · filed 2020-03-12 | $228.00K 10-K · filed 2020-03-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$1.00K derived: sum of 2 quarters · filed 2018-11-06 | $228.00K 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $228.00K 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | $229.00K 10-Q · filed 2018-05-08 |